Vicarious Surgical Q2 net loss narrows to $13.2M; CEO transition to Stephen From

Vicarious Surgical Inc.

GAAP net loss of $13.2M ($2.23/share) vs. $15.2M ($2.59/share) in Q2 2024.
Operating expenses fell 24% YoY to $13.5M; R&D $9.1M, G&A $4.1M, S&M $0.3M.
Cash and investments $24.0M; Q2 cash burn $13.4M; FY2025 cash burn guidance ~$50M.
Adam Sachs becomes President; Stephen From appointed CEO effective August 12, 2025.
Non-GAAP adjusted net loss $13.3M ($2.23/share) vs. $16.8M ($2.86/share) year ago.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.